[1]
Komiljonov, K. et al. 2025. CLINICAL OUTCOMES OF INTRAVESICAL CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER. Academic research in modern science. 4, 55 (Sep. 2025), 130–132. DOI:https://doi.org/10.5281/zenodo.17233238.